ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US00370M1036

SecurityABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
InstitutionGAMMA Investing LLC
Latest Disclosed Ownership548 shares
Latest Disclosed Value $ 61,020
GAMMA Investing LLC reports 1.44% decrease in ownership of ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)

On April 6, 2026 - GAMMA Investing LLC filed a 13F-HR form disclosing ownership of 548 shares of ABIVAX Société Anonyme - Depositary Receipt (Common Stock) (US:ABVX) valued at $61,020 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 5, 2026 disclosing 556 shares of ABIVAX Société Anonyme - Depositary Receipt (Common Stock). This represents a change in shares of -1.44% during the quarter. The current value of the position is $55,638 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-06 2026-03-31 13F ABIVAX SA SPONSORED ADS ADR 00370M103 548 -8 -1.44 61 -17.57 0.0028
2026-01-05 2025-12-31 13F ABIVAX SA SPONSORED ADS ADR 00370M103 556 -82 -12.85 75 37.04 0.0038
2025-10-02 2025-09-30 13F ABIVAX SA SPONSORED ADS ADR 00370M103 638 -7 -1.09 54 1,250.00 0.0030
2025-07-14 2025-06-30 13F ABIVAX SA SPONSORED ADS ADR 00370M103 645 -2,368 -78.59 5 -77.78 0.0003
2025-04-15 2025-03-31 13F/A-1 ABIVAX SA SPONSORED ADS ADR 00370M103 3,013 -963 -24.22 19 -37.93 0.0014
2025-04-07 2025-03-31 13F ABIVAX SA SPONSORED ADS ADR 00370M103 18,831 14,855 3 0.0161
2025-01-03 2024-12-31 13F ABIVAX SA SPONSORED ADS ADR 00370M103 3,976 3,976 29 0.0025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.